« Back to Record
Citation APA

De Moerloose, B., Suciu, S., Bertrand, Y., Mazingue, F., Robert, A., Uyttebroeck, A., Yakouben, K., Ferster, A., Margueritte, G., Lutz, P., Munzer, M., Sirvent, N., Norton, L., Boutard, P., Plantaz, D., Millot, F., Philippet, P., Baila, L., Benoît, Y., Otten, J., & Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC), (2010). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood, 116(1), 36-44. doi:10.1182/blood-2009-10-247965


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/96424

De Moerloose, B., Suciu, S., Bertrand, Y., Mazingue, F., Robert, A., Uyttebroeck, A., Yakouben, K., Ferster, A., Margueritte, G., Lutz, P., Munzer, M., Sirvent, N., Norton, L., Boutard, P., Plantaz, D., Millot, F., Philippet, P., Baila, L., Benoît, Y., Otten, J., & Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC), (2010). Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood, 116(1), 36-44. doi:10.1182/blood-2009-10-247965